Belviq沛丽婷

Category:

Description

新减重药Belviq (沛丽婷)于2012年在美国核准上市,隔了5年终于通过审查在台湾上市。沛丽婷可以减少血清素(Serotonin)的回收,并且选择性的作用在下视丘(Hypothalamus)饱食中枢5-HT2c 接受体,产生饱足感,减低食欲,

Reviews

There are no reviews yet.

Be the first to review “Belviq沛丽婷”

Your email address will not be published. Required fields are marked *